Update on divestment of Aspen’s Nutritionals business to Lactalis ASPEN PHARMACARE HOLDINGS LIMITED (Incorporated in the Republic of South Africa) (“Aspen Holdings”) Registration number: 1985/0002935/06 Share code: APN ISIN: ZAE000066692 and its subsidiaries (collectively “Aspen” or “the Group”) UPDATE ON DIVESTMENT OF ASPEN’S NUTRITIONALS BUSINESS TO LACTALIS With reference to previous announcements in respect of the Group’s divestment of its Nutritionals Business to the Lactalis Group (“Lactalis”), Aspen is pleased to confirm that it has, earlier this morning, received confirmation from Lactalis that the New Zealand Overseas Investment Office has granted approval to Lactalis for the acquisition of Aspen’s business in that country. All conditions precedent requiring third party consents and approvals for the divestment by Aspen of its Nutritionals Business to Lactalis have now been fulfilled, with the remaining conditions precedent being within the control of the parties. The parties are mutually committed to closure on 31 May 2019. Sponsor Investec Bank Limited Durban 17 May 2019 Sponsor: Investec Bank Limited Date: 17/05/2019 08:50:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.
Email this JSE Sens Item to a Friend.